IP Library Granted Patent US 11,109,773
Granted Patent B2
US 11,109,773 · App. 15/840,191 · Granted Sep 7, 2021

Treating patients with TTFields with the electrode positions optimized using deformable templates

Inventors: Noa Urman (Pardes Hanna Carcur, IL); Zeev Bomzon (Kiryat Tivon, IL)
Assignee: Novocure GmbH
A61B5/055A61B5/0042A61N1/0476A61N1/32A61N1/36002A61N1/36025A61N1/40G06F30/20G16H20/40G16H30/40G16H50/20G16H50/50A61B5/053A61B2576/026A61N1/0456A61N1/0529A61N1/08G16H50/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,109,773
App. No.
15/840,191
Granted
Sep 7, 2021
Kind
B2
Abstract

Embodiments receive images of a body area of a patient; identify abnormal tissue in the image; generate a data set with the abnormal tissue masked out; deform a model template in space so that features in the deformed model template line up with corresponding features in the data set; place data representing the abnormal tissue back into the deformed model template; generate a model of electrical properties of tissues in the body area based on the deformed and modified model template; and determine an electrode placement layout that maximizes field strength in the abnormal tissue by using the model of electrical properties to simulate electromagnetic field distributions in the body area caused by simulated electrodes placed respective to the body area. The layout can then be used as a guide for placing electrodes respective to the body area of the patient to apply TTFields to the body area.

Claims (57)

1. A method for improving treatment of a tumor using Tumor Treating Fields (TTFields), the method comprising:

receiving, by a processor of a computer system, a three-dimensional image of a body area of a patient;

identifying portions of the image that correspond to abnormal tissue;

generating a data set corresponding to the image with the abnormal tissue masked out;

retrieving a model template from a memory device of the computer system, the model template comprising tissue probability maps that specify positions of a plurality of tissue types in a corresponding body area of a healthy individual that is distinct from the patient;

deforming the model template in space so that features in the deformed model template line up with corresponding features in the data set;

modifying portions of the deformed model template that correspond to the masked-out portion of the data set so that the modified portions represent the abnormal tissue;

generating a model of electrical properties of tissues in the body area based on (a) the positions of the plurality of tissue types in the deformed and modified model template and (b) a position of the abnormal tissue in the deformed and modified model template;

determining an electrode placement layout that maximizes field strength in at least a portion of the abnormal tissue by using the model of electrical properties to simulate electromagnetic field distributions in the body area caused by simulated electrodes placed at a plurality of different sets of candidate positions respective to the body area, and selecting one of the sets;

placing the electrodes respective to the body area of the patient based on the determined electrode placement layout; and

using the placed electrodes to apply TTFields to the body area.

2. An electrotherapeutic treatment device comprising a processor configured to execute instructions stored in one or more memory devices to perform an electrotherapeutic treatment comprising:

receiving, by the processor, a three-dimensional image of a body area of a patient;

identifying portions of the image that correspond to abnormal tissue;

generating a data set corresponding to the image with the abnormal tissue masked out;

retrieving a model template from the one or more memory devices, wherein the model template specifies positions of a plurality of tissue types in a corresponding body area of a healthy individual that is distinct from the patient;

deforming the model template in space so that features in the deformed model template line up with corresponding features in the data set;

modifying portions of the deformed model template that correspond to the masked-out portion of the data set so that the modified portions represent the abnormal tissue;

generating a model of electrical properties of tissues in the body area based on (a) the positions of the plurality of tissue types in the deformed and modified model template and (b) a position of the abnormal tissue in the deformed and modified model template;

determining an electrode placement layout that maximizes field strength in at least a portion of the abnormal tissue by using the model of electrical properties to simulate electromagnetic field distributions in the body area caused by simulated electrodes placed at a plurality of different sets of candidate positions respective to the body area, and selecting one of the sets; and

outputting the determined electrode placement layout for subsequent use as a guide for placing electrodes respective to the body area of the patient prior to use of the electrodes for electrotherapeutic treatment.

3. A method for improving an electrotherapeutic treatment comprising:

receiving, by a processor of a computer system, a three-dimensional image of a body area of a patient;

identifying portions of the image that correspond to abnormal tissue;

generating a data set corresponding to the image with the abnormal tissue masked out;

retrieving a model template from a memory device of the computer system, wherein the model template specifies positions of a plurality of tissue types in a corresponding body area of a healthy individual that is distinct from the patient;

deforming the model template in space so that features in the deformed model template line up with corresponding features in the data set;

modifying portions of the deformed model template that correspond to the masked-out portion of the data set so that the modified portions represent the abnormal tissue;

generating a model of electrical properties of tissues in the body area based on (a) the positions of the plurality of tissue types in the deformed and modified model template and (b) a position of the abnormal tissue in the deformed and modified model template;

determining an electrode placement layout that maximizes field strength in at least a portion of the abnormal tissue by using the model of electrical properties to simulate electromagnetic field distributions in the body area caused by simulated electrodes placed at a plurality of different sets of candidate positions respective to the body area, and selecting one of the sets; and

outputting the determined electrode placement layout for subsequent use as a guide for placing electrodes respective to the body area of the patient prior to use of the electrodes for electrotherapeutic treatment.

4. The method of claim 3 , wherein the identifying of the portions of the image that correspond to the abnormal tissue comprises performing segmentation of the image.

5. The method of claim 3 , wherein the model of electrical properties of tissues comprises a model of electrical conductivity or resistivity.

6. The method of claim 3 , wherein the image comprises an MRI image, or a CT image.

7. The method of claim 3 , wherein the body area comprises a head of the patient.

8. The method of claim 3 , wherein the portions of the image that correspond to the abnormal tissue correspond to a tumor.

9. The method of claim 3 , wherein the electrotherapeutic treatment comprises Tumor Treating Fields (TTFields).

10. The method of claim 3 , wherein the model template is selected from a plurality of model templates based on similarities between the image and each of the model templates.

11. The method of claim 3 , further comprising:

placing the electrodes respective to the body area of the patient based on the determined electrode placement layout; and

using the electrodes to apply TTFields to the body area.

12. The method of claim 3 , wherein the determining of the electrode placement layout comprises:

applying a boundary condition to the simulated electrodes in each one of at least two electrode placement layouts;

solving a field distribution in the body area for each one of the at least two electrode placement layouts; and

choosing the electrode placement layout that yields the strongest field within the abnormal tissue.

13. The method of claim 12 , wherein the boundary condition corresponds to voltages or currents applied to the simulated electrodes.

14. The method of claim 3 , wherein the deforming of the model template comprises:

determining a mapping that maps the data set to a coordinate space of the model template; and

applying an inverse of the mapping to the model template.

15. The method of claim 14 , wherein the mapping is determined for points in the data set that fall outside of the masked-out portion.

16. The method of claim 14 , wherein the model template comprises tissue probability maps, wherein the mapping maps the data set to the tissue probability maps.

17. The method of claim 16 , wherein the tissue probability maps are existing tissue probability maps derived from images of multiple individuals.

18. The method of claim 16 , wherein the tissue probability maps are derived from images of the healthy individual from whom the model template has been derived.

19. The method of claim 18 , wherein the tissue probability maps are derived by simultaneously registering and segmenting the images of the healthy individual using existing tissue probability maps, and wherein the existing tissue probability maps are derived from images of multiple individuals.

20. The method of claim 16 , wherein the inverse of the mapping is applied to each one of the tissue probability maps, wherein the inverse-mapped tissue probability maps are combined into a segmented image comprising the deformed model template.

21. The method of claim 20 , wherein combining the inverse-mapped tissue probability maps includes assigning to each voxel the tissue type which has the highest probability of occupying that voxel across the inverse-mapped tissue probability maps.

22. The method of claim 20 , wherein combining the inverse-mapped tissue probability maps includes using a look-up table to assign a tissue type to each voxel that is assigned more than one tissue type across the inverse-mapped tissue probability maps.

Assignments (12)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
SECURITY INTEREST Recorded Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
SUPPLEMENTAL RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 45284 0851 Recorded Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0253 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 45278 0825 Recorded Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0335 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 50395/0398 Recorded Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
OMNIBUS CONFIRMATION OF ASSIGNMENT AGREEMENT Recorded May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
SECURITY INTEREST Recorded May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2018
From: URMAN, NOA; BOMZON, ZEEV
To: NOVOCURE LIMITED
Reel/Frame 045809/0231 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045284/0851 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045278/0825 →
Continuity (2)
Provisional Application 62433501 · Dec 13, 2016
Related Publication 20180160933A1 · Jun 14, 2018
Cited By (5)
US 12,208,275 US 12,311,167 US 12,515,045 US 12,646,609 US 12,699,453